Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Insiders Buy More Than $19M Of 3 Stocks

Published 10/03/2022, 12:10
Updated 10/03/2022, 13:11
© Reuters.  Insiders Buy More Than $19M Of 3 Stocks
XM
-

Although US stocks closed sharply higher on Wednesday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

JELD-WEN Holding

  • The Trade: JELD-WEN Holding, Inc. (NYSE: JELD) 10% owner Turtle Creek Asset Management Inc acquired a total of 355,000 shares at an average price of $22.33. To acquire these shares, it cost around $7.93 million.
  • What’s Happening: JELD-WEN’s current CFO, John Linker, decided to resign to pursue another CFO opportunity and transition his responsibilities by the end of March.
  • What JELD-WEN Does: JELD-WEN Holding Inc is engaged in door and window manufacturing. The company design, produce and distribute interior and exterior doors, windows, and related products.
  • The Trade: Revolution Medicines, Inc. (NASDAQ: RVMD) Director Thilo Schroeder acquired a total of 246,438 shares at an average price of $18.91. To acquire these shares, it cost around $4.66 million.
  • What’s Happening: Revolution Medicines recently posted a Q4 loss of $0.71 per share.
  • What Revolution Medicines Does: Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Qualtrics International

  • The Trade: Qualtrics International Inc. (NASDAQ: XM) Director Egon Durban bought a total of 254,439 shares at an average price of $26.89. To acquire these shares, it cost around $6.84 million.
  • What’s Happening: Infosys, last month, reported collaboration with Qualtrics to help enterprises deliver personalized experiences.
  • What Qualtrics International Does: Qualtrics International Inc is a software technology company based in the United States. It develops software for organizations.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.